Company profile
VACCINEX, INC. CIK 1205922
Ticker
VCNX (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Rochester, NY 14620
Fiscal year end
2024 (FY)
Key Financials
Revenue
$601.0K
Net income
-$18.63M
Total assets
$2.60M
Total liabilities
$5.08M
Stockholders' equity
-$2.49M
Cash & equivalents
$1.11M
Operating income
-$18.74M
Operating cash flow
-$16.19M
Capital expenditures
$22.0K
Fiscal year 2024, via 10-K filed 2025-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-3,117.3%
Net margin
-3,100.5%
Free cash flow
-$16.21M
Free cash flow margin
-2,696.8%
Liabilities / assets
195.8%
Equity / assets
-95.8%
CapEx / revenue
3.7%
Operating cash flow / net income
0.87×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
$601.0K
-$18.63M
$2.60M
$5.08M
-$2.49M
2023
$570.0K
-$20.25M
$3.63M
$5.94M
-$2.31M
2022
$275.0K
-$19.82M
$7.98M
$2.78M
$5.19M
2021
$900.0K
-$22.38M
$9.84M
$2.43M
$7.41M
2020
$625.0K
-$28.85M
$11.70M
$14.31M
-$26.58M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-K
2025-04-15
Financials filed via
Form 10-K
filed 2025-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Rochester, NY 14620
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:42 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.